Author

Jing Liu

Institutions: Shanghai Medical College of Fudan University, Fudan University, Tianjin Medical University Cancer Institute and Hospital, Fudan University Shanghai Cancer Center

Observed institutions: Shanghai Medical College of Fudan University, Fudan University, Tianjin Medical University Cancer Institute and Hospital, Fudan University Shanghai Cancer Center

ORCID: 0000-0002-8181-8159

Observed ORCID: 0000-0002-8181-8159

OpenAlex ID: A5122593330

KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy

2026 · Jing Liu, Xupeng Hou, et al. · Gut · 6

Works count: 1

Citation count: 5

H-index: 1

I10-index: